Table 2.
Trial | Patients (DGHL/Control) | Treatment success (DGHL/Control) | Operative time (min) (DGHL/Control) | Complications (DGHL/Control) | Pain VAS score (DGHL/Control) | Recurrence (DGHL/Control) |
---|---|---|---|---|---|---|
Bursics A, et al | 30/30 | 25/26 | Not reported | 6/5 | Not reported | Not reported |
Festen S, et al | 23/18 | 18/15 | Not reported | 2/3 | 3.1 ± 0.1/5.1 ± 0.1 | 5/5 |
Gupta PJ, et al | 22/23 | Not reported | 31 ± 5.4/9 ± 6.3 | 4/4 | Not reported | 4/3 |
Infantino A, et al | 85/84 | Not reported | 26.6 ± 8.4/25.7 ± 7.8 | 26/33 | 2.0 ± 0.5/2.4 ± 0.5 | 12/6 |
Shuurman JP, et al | 38/35 | 8/11 | Not reported | 3/0 | 3.9 ± 1.0/4.5 ± 1.0 | 30/30 |